- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05411341
Comparison of Two Different Optical Biometric Systems
February 23, 2026 updated by: Georgios Labiris, Democritus University of Thrace
Assessment of Two Different Optical Biometric Systems, Based on Different Optical Technologies in Patients With Cataract or Presbyopia
Primary objective of this study is to evaluate and compare the measurements of two different optical biometrics systems in patients who will undergo cataract surgery or presbyopia surgery using intraocular lenses (IOL-PC).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a prospective study including patients visiting the outpatient Ophthalmology clinic of the University General Hospital of Alexandroupolis, who suffer from diagnosed cataract or presbyopia and are going to undergo implantation of intraocular lenses surgery.
The patients will be fully informed about the procedure and the purpose of the study and a written informed consent will be provided by all participants.
They will then undergo an ocular biometry examination using two optical biometric systems, Argos (Alcon Laboratories, Inc.) and IOLMaster 500 (Carl Zeiss Meditec AG).
IOL Master 500 (Carl Zeiss Meditec AG) is a non-invasive optical biometer that uses partial coherence interferometry (PCI) with a wavelength of 780 nm to measure the AL of the eye.
Argos (Alcon Laboratories, Inc.) is a novel non-invasive optical biometer that uses swept source optical coherence tomography (SS-OCT) with a wavelength of 1050 nm.
The measurements of the two systems that will be compared are the axial length, the keratometry values, the anterior chamber depth (ACD), the horizontal corneal diameter (white to white [WTW]) and the lens power in diopters (D).
Study Type
Observational
Enrollment (Actual)
133
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Evros
-
Alexandroupoli, Evros, Greece, 68100
- Department of Ophthalmology, University Hospital of Alexandroupolis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 81 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Adult patients with cataract and/or presbyopia.
Description
Inclusion Criteria:
- Patients with cataract and/or presbyopia who will undergo intraocular lens implantation.
Exclusion Criteria:
- Dense cataract that does not allow measurements to be taken with an optical biometrics system.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study Group
100 patients with diagnosed cataract or presbyopia who will undergo implantation of intraocular lenses surgery
|
An ocular biometry examination will be performed on the affected eyes using the Argos device.
An ocular biometry examination will be performed on the affected eyes using the IOL Master 500 device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Axial length
Time Frame: 1 week
|
The measurement of the axial length of the affected eye using both devices
|
1 week
|
|
Keratometry values
Time Frame: 1 week
|
The measurement of keratometry values K1: flat meridian of the anterior corneal surface and K2: steep meridian of the anterior corneal surface of the affected eye using both devices.
|
1 week
|
|
Lens power (D)
Time Frame: 1 week
|
The power of the lens is calculated by each device as a function of biometric measurements
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anterior chamber depth (ACD)
Time Frame: 1 week
|
The measurement of the anterior chamber depth (ACD) of the affected eye using both devices.
|
1 week
|
|
Horizontal corneal diameter (white to white [WTW])
Time Frame: 1 week
|
The measurement of the horizontal corneal diameter of the affected eye using both devices.
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Georgios Labiris, MD, PhD, Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2023
Primary Completion (Actual)
April 30, 2024
Study Completion (Actual)
May 31, 2024
Study Registration Dates
First Submitted
June 6, 2022
First Submitted That Met QC Criteria
June 6, 2022
First Posted (Actual)
June 9, 2022
Study Record Updates
Last Update Posted (Actual)
February 24, 2026
Last Update Submitted That Met QC Criteria
February 23, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ES9/Th3/05-05-2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Colvard Kandavel Eye CenterEnrolling by invitationCataract | Cataract Bilateral | Cataract Surgery | Cataract (Post-operative Cataract Surgery Follow-up)United States
-
Matthew RauenNot yet recruitingNuclear Cataract | Cataract Surgery Anesthesia | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Züleyha SönmezAtaturk UniversityActive, not recruitingCataract Surgery | Cataract Patients | Cataract After SurgeryTurkey (Türkiye)
-
Stanford UniversityEnrolling by invitationIntraocular Lens | Cataract Extraction | Cataract Surgery | Eye Disorders | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Seva Canada SocietyPragyaan Sustainable Health Outcomes Foundation; Sadgura Netra ChikitsalayaNot yet recruitingCataract (Post-operative Cataract Surgery Follow-up)
-
Nicole Fram M.D.RecruitingCataract Bilateral | Nuclear Sclerosis of the Lens | Phacoemulsification Cataract SurgeryUnited States
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
Clinical Trials on Argos (Alcon Laboratories, Inc.)
-
University of California, BerkeleyCompletedCorneal Epithelial Permeability
-
Asociación para Evitar la Ceguera en MéxicoTerminated
-
Walailak UniversityCompleted
-
Summers LaboratoriesCompleted
-
Valley Laser Eye CentreSengiCompleted
-
Thinq Pharma-CRO Pte. Ltd.Unique Pharmaceuticals Ltd, India; THINQ Pharma CRO Ltd.UnknownOropharyngeal CandidiasisIndia
-
Beaver-Visitec International, Inc.Completed
-
Parc de Salut MarCompletedCataract Senile | Lenses, Intraocular